🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a single institution study of combining decitabine with fludarabine...
Status
Completed
Location
Hackensack University Medical Center - John Theurer Cancer Center
Start Date
2009-05
Trial ID
NCT01455506
Treatments Being Tested
This study compares haplo-identical family donor stem cell transplantation ...
Status
Terminated
Location
Medical University of Vienna
Start Date
2019-11-12
Trial ID
NCT04067180
The purpose of the study is to assess the safety and efficacy of haploident...
Status
Unknown
Location
First Affiliated Hospital of Guangxi Medical University
Start Date
2017-04-01
Trial ID
NCT03171831
RATIONALE: Giving low doses of chemotherapy, such as fludarabine, and total...
Status
Terminated
Location
OHSU Knight Cancer Institute
Start Date
2003-05
Trial ID
NCT00416884
Treatments Being Tested
An Open-label, Phase II, Two-stage, Study of Xantrene® (Bisantrene) in comb...
Status
Unknown
Location
Chaim Sheba Medical Center
Start Date
2021-08-02
Trial ID
NCT04989335
Treatments Being Tested
This is a single arm,open-label, non-randomized phase 2 study to determine ...
Status
Unknown
Location
Shanghai Mengchao Cancer Hospital
Start Date
2021-06-04
Trial ID
NCT05472610
Treatments Being Tested
Background: * Severe aplastic anemia (SAA) can lead to problems with bone ...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2010-08
Trial ID
NCT01187017
Treatments Being Tested
This is a Phase II study following subjects proceeding with our Institution...
Status
Recruiting
Location
Masonic Cancer Center at University of Minnesota
Start Date
2023-05-01
Trial ID
NCT05805605
Severe aplastic anemia is a rare and serious form of bone marrow failure re...
Status
Recruiting
Location
Blood and Marrow Transplant Group of Georgia
Start Date
2016-09-09
Trial ID
NCT02828592
Treatments Being Tested
The aim of this study is to analyze the safety of BAFF-R Chimeric Antigen R...
Status
Recruiting
Location
Institute of Hematology and Blood Diseases Hospital ,Chinese Academy of Medical Sciences
Start Date
2025-11-29
Trial ID
NCT07259070
Treatments Being Tested